Authors' recommendations: The health technology assessment completed by Health Quality Ontario is available separately. A completed decision determinants framework is included in this report. The key findings of the health technology assessment were: - Based on available evidence of moderate quality, the Argus II retinal prosthesis system improved visual function, functional outcomes and quality of life in patients with severe vision loss from advanced retinitis pigmentosa at 3-year follow-up - There was a trend toward an improved safety profile of the Argus II retinal prosthesis system as the technology evolves and the surgeons refine their skills - The Argus II retinal prosthesis system would be cost-effective only if the "willingness to pay" were more than $207,616 per quality-adjusted life year (QALY) gained - The budget impact of funding the Argus II retinal prosthesis system at one Ontario centre would range from $800,404 to $837,596 over the next 5 years - Patients described the Argus II retinal prosthesis system as enabling perception of light/dark and shapes/objects, having a positive impact on quality of life

Project Status: Completed

Year Published: 2016

URL for published report: http://www.hqontario.ca/Portals/0/Documents/evidence/reports/recommendation-retinal-prosthetics-en-1606.pdf

English language abstract: An English language summary is available

Publication Type: Not Assigned

Country: Canada

Organisation Name: Health Quality Ontario

Contact Address: Evidence Development and Standards, Health Quality Ontario, 130 Bloor Street West, 10th floor, Toronto, Ontario Canada M5S 1N5

Contact Name: EDSinfo@hqontario.ca

Contact Email: OH-HQO_hta-reg@ontariohealth.ca

Copyright: Health Quality Ontario (HQO)